Framingham Heart Study

This study has been completed.

First Received: May 25, 2000 Last Updated: April 13, 2009 History of Changes

Sponsored by:	National Heart, Lung, and Blood Institute (NHLBI)
Information provided by:	National Heart, Lung, and Blood Institute (NHLBI)
ClinicalTrials.gov Identifier:	NCT00005121

Purpose

The Framingham Heart Study was initiated to study the factors associated with the development of cardiovascular disease by employing long-term surveillance of an adult population in Framingham, Massachusetts. The Framingham Offspring Study was initiated to assess familial and genetic factors as determinants of coronary heart disease.

Condition	Phase
Cardiovascular Diseases Heart Diseases Coronary Disease Cerebrovascular Accident Hypertension Heart Failure, Congestive Peripheral Vascular Diseases Arterial Occlusive Diseases Atherosclerosis Heart Failure	N/A

MedlinePlus related topics: Coronary Artery Disease Heart Diseases Heart Failure High Blood Pressure Peripheral Arterial Disease Vascular Diseases

U.S. FDA Resources

Study Type:

Observational

Further study details as provided by National Heart, Lung, and Blood Institute (NHLBI):

Study Start Date:	July 1948
Study Completion Date:	September 2008
Primary Completion Date:	September 2008 (Final data collection date for primary outcome measure)

Show Detailed Description

Eligibility

Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

No eligibility criteria

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00005121

Sponsors and Collaborators

National Heart, Lung, and Blood Institute (NHLBI)

Investigators

Investigator:	Philip Wolf	Boston University
Investigator:	Philip Wolf	Boston University

More Information

Additional Information:

Related Info This link exits the ClinicalTrials.gov site

No publications provided

Study ID Numbers:	900
Study First Received:	May 25, 2000
Last Updated:	April 13, 2009
ClinicalTrials.gov Identifier:	NCT00005121 History of Changes
Health Authority:	United States: Federal Government

Study placed in the following topic categories:

Atherosclerosis
Arterial Occlusive Diseases
Heart Failure
Heart Diseases
Peripheral Vascular Diseases
Cerebral Infarction
Myocardial Ischemia
Stroke
Vascular Diseases
Central Nervous System Diseases

Ischemia
Arteriosclerosis
Brain Diseases
Cerebrovascular Disorders
Coronary Disease
Brain Ischemia
Brain Infarction
Infarction
Coronary Artery Disease
Hypertension

Additional relevant MeSH terms:

Arterial Occlusive Diseases
Atherosclerosis
Heart Failure
Heart Diseases
Peripheral Vascular Diseases
Cerebral Infarction
Myocardial Ischemia
Nervous System Diseases
Stroke
Vascular Diseases

Central Nervous System Diseases
Arteriosclerosis
Brain Diseases
Cerebrovascular Disorders
Coronary Disease
Brain Ischemia
Cardiovascular Diseases
Brain Infarction
Coronary Artery Disease
Hypertension

ClinicalTrials.gov processed this record on May 07, 2009